openPR Logo
Press release

Grand Mal Seizure Treatment Market is Estimated to be US$ 3.2 Billion with a CAGR of 4.5% by 2033

05-20-2024 06:08 AM CET | Health & Medicine

Press release from: Fact.MR

Grand Mal Seizure Treatment Market

Grand Mal Seizure Treatment Market

According to Fact.MR, a market research and competitive intelligence service, the global grand mal seizure therapy market is worth $2 billion in 2023 and is expected to grow to $3.2 billion by 2033.

The grand mal seizure therapy market is likely to be driven by the rising frequency of epilepsy and other neurological illnesses, as well as advances in medical technologies and seizure research.

Antiepileptic medications (AEDs) are the main treatment for grand mal seizures. There are a variety of medications available for seizure treatment.

For more insights into the Market, Request a Sample of this Report:
https://www.factmr.com/connectus/sample?flag=S&rep_id=8547

Grand mal seizures, also known as generalized tonic-clonic seizures, are marked by rapid and severe convulsions that impact the entire body and can result in unconsciousness.

According to the National Center for Biotechnology Information, around 12 million individuals in India suffer from epilepsy, making it the country with the highest prevalence.
This illness is frequently linked to epilepsy, a neurological disorder that affects some 50 million people worldwide, according to the World Health Organization.
Healthcare providers are increasingly looking for therapy solutions that can successfully manage seizures while minimizing the risk of adverse consequences. This has resulted in the creation of newer AEDs and other drugs that are more effective and well tolerated than older treatments. Wearable gadgets are also expected to have a significant impact on the condition's treatment.

Get Customization on this Report for Specific Research Solutions:
https://www.factmr.com/connectus/sample?flag=RC&rep_id=8547

Key Takeaways from Market Study

Sales of grand mal seizure treatment options are predicted to grow at a CAGR of 4.5% between 2023 and 2033.
The global grand mal seizure therapy market is expected to reach $3.2 billion by the end of 2033.
North America dominates the global market due to the high prevalence of epilepsy and the presence of important market participants in the area.
The European market is growing fast due to the existence of well-established healthcare facilities and increased medical tourism in the region.
With the emergence of new wearable technology that can capture enhanced information on seizure attacks, the grand mal seizure therapy market is becoming more prominent, says a Fact.MR analyst.

Recent Market Developments

Top companies in the grand mal seizure treatment industry are investing heavily in R&D activities to create unique and cutting-edge grand mal seizure drugs. This increases their competitiveness and drives revenue growth.

The United States Food and Drug Administration approved Lupin's abbreviated new drug application (ANDA) for Vigabatrin in March 2022. It is an anti-epileptic medicine available as a 500 mg oral solution USP.
Marinus Pharmaceuticals' drug Ztalmy was approved by the United States Food and Drug Administration in March 2022 to treat seizures in persons with CDKL5 deficiency, a genetic cause of epilepsy.

Key Segments of Grand Mal Seizure Treatment Industry Research

By Drug Generation:
First
Second
Third
By Drug Class:
Barbiturates
Hydantoin
Phenyltriazine
Iminostilbenes
Benzodiazepines
Aliphatic Carboxylic Acids
By Diagnosis:
Magnetic Resonance Imaging
Electroencephalogram
Blood Tests
Computed Tomography
By End User:
Hospitals
Clinics
Academic and Research Centers

𝐑𝐞𝐚𝐝 𝐌𝐨𝐫𝐞: https://www.factmr.com/report/grand-mal-seizure-treatment-market

More Valuable Insights on Offer

Fact.MR, in its new offering, presents an unbiased analysis of the global grand mal seizure treatment market, presenting historical demand data (2018 to 2022) and forecast statistics for the period (2023 to 2033).

The study divulges essential insights on the market based on drug generation (first, second, third), drug class (barbiturates, hydantoin, phenyltriazine, iminostilbenes, benzodiazepines, aliphatic carboxylic acids), diagnosis (magnetic resonance imaging, electroencephalogram, blood tests, computed tomography), and end user (hospitals, clinics, academic and research centers), across five major regions of the world.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭:

US Sales Office
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Tel: +1 (628) 251-1583, +353-1-4434-232
Email: sales@factmr.com

𝐀𝐛𝐨𝐮𝐭 𝐅𝐚𝐜𝐭.𝐌𝐑

We are a trusted research partner of 80% of fortune 1000 companies across the globe. We are consistently growing in the field of market research with more than 1000 reports published every year. The dedicated team of 400-plus analysts and consultants is committed to achieving the utmost level of our client's satisfaction.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Grand Mal Seizure Treatment Market is Estimated to be US$ 3.2 Billion with a CAGR of 4.5% by 2033 here

News-ID: 3502574 • Views:

More Releases from Fact.MR

Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB Ltd, ANSYS, Inc, AT&T Inc, AVEVA Group plc, Bentley Systems
Digital Twin Market is Growing at a CAGR of 34.3% d by 2033 | Key Players: ABB L …
Digital Twin Market is valued at USD 5 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 34.3%, reaching USD 95 billion by 2033. This explosive growth is driven by the increasing adoption of digital twins across industries to optimize operations, reduce costs, and enhance decision-making through virtual replicas of physical assets. Digital twins integrate IoT, AI, and data analytics to simulate real-world
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Hemato Oncology Testing Market is Forecasted to Reach USD 23.64 Billion by 2033 …
The global hemato oncology testing market is valued at USD 4.33 billion in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 18.5%, reaching USD 23.64 billion by 2033. This rapid growth is driven by the increasing prevalence of blood-related cancers, such as lymphoma and leukemia, and advancements in diagnostic technologies like next-generation sequencing (NGS) and polymerase chain reaction (PCR). Hemato oncology testing plays a
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 2035
09-02-2025 | Health & Medicine
Fact.MR
Osseointegration Implants Market is Anticipated to Reach USD 6.85 Billion by 203 …
Osseointegration Implants Market is poised for robust growth, with its valuation projected to rise from USD 3.17 billion in 2025 to USD 6.85 billion by 2035, reflecting a compound annual growth rate (CAGR) of 8%. This expansion is driven by the increasing prevalence of orthopedic and dental disorders, such as osteoarthritis, rheumatoid arthritis, and edentulism, which necessitate advanced implant solutions. Osseointegration implants, which fuse directly with bone to provide stable
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.MR Report
09-02-2025 | Health & Medicine
Fact.MR
Fibrin Sealants Market is Anticipated to Reach USD 1.92 Billion by 2033 | Fact.M …
The global fibrin sealants market is valued at USD 976.5 million in 2023 and is projected to expand at a compound annual growth rate (CAGR) of 7%, reaching USD 1.92 billion by 2033. This growth is driven by the increasing prevalence of surgical procedures requiring effective hemostasis and tissue sealing, particularly in cardiovascular, orthopedic, and general surgeries. Fibrin sealants, derived from human plasma proteins, mimic the body's natural clotting process,

All 5 Releases


More Releases for Grand

Gaurav Properties Celebrates Milestone with Grand Success Party at Hotel Delite …
Gaurav Properties, one of the city's most trusted real estate agencies, celebrated its latest success with a heartwarming and joyful gathering at Hotel Delite Grand, Faridabad. The event marked a significant milestone in the company's growth, achievements, and strong client trust across the region. The success party, attended by the entire Gaurav Properties team, was filled with positivity, laughter, and appreciation. With consistent performance, excellent client service, and an expanding portfolio of
Dunkin's Diamonds Grand Opening
Dunkin's Diamonds 2015 Schorrway Drive NW Lancaster, Ohio 43130 740-653-9756 www.dunkinsdiamonds.com hello@dunkinsdiamonds.com FOR IMMEDIATE RELEASE Dunkin's Diamonds is excited to announce the grand opening of our new location celebration. After over 20 years in the River Valley Mall, loyalty from all our customers has fueled continued growth, making a move necessary, with more space we are able to offer you more showroom, larger selection of our fine jewelry collection and a better
Grand Opening
FOR IMMEDIATE RELEASE Samurai Hire 06-Apr-21 We treat candidates like they are our masters – serving them is the highest honor! What if recruiters actually cared about candidates and did everything they could to serve them? Johns Island, SC, Samurai Hire opened its doors for the first time on 01-Apr-21. "I slice through the red-tape most candidates experience looking for a new opportunity. I specialize in recruiting in the IT and Healthcare space. There’s
Airhart Construction Grand Opens
Airhart Construction is preparing to unveil a new fully furnished Farmington model on Saturday, October 22 at Fisher Farm, its low-maintenance community of 71 semi-custom single-family homes in Winfield. The debut of the new model—featuring Airhart Construction’s most in-demand floorplan—is good news for buyers who desire a customizable design, open layout, and plentiful standard amenities, said Christy Whelan, director of sales for Airhart Construction. “Even more exciting news is,” Whelan added, “is
New York hotels Soho Grand and Tribeca Grand launch GrandLife Rewards
Guests at the renowned New York hotels, the Soho Grand and Tribeca Grand, can now benefit from GrandLife Rewards, a new preferred guest program. New York’s celebrated Soho Grand and Tribeca Grand Hotels have just launched GrandLife Rewards, their new guest loyalty program aimed at rewarding their loyal customers at a rate double to that of their previous program. Members now receive two points for every dollar spent. The points driven program
Grand Canyon Whitewater’s Facelift Makes for Beautiful Grand Canyon Rafting Va …
Grand Canyon Whitewater has a new style and is looking fine. Grand Canyon Whitewater has been primping all winter long, preparing for your Grand Canyon rafting trip this summer! We are aiming to be the host with the most, and show you the adventure of a lifetime in comfort and style on your next Colorado River rafting trip. With Grand Canyon Whitewater, living in the wilderness can be as comfortable